Cargando…
Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers
BACKGROUND: Resveratrol (Res) inhibits ovarian cancer (OC) cell growth but its in vivo anti-OC effects are unclear due to the low bioavailability of systemically administered Res. Intraperitoneal administration may overcome this therapeutic dilemma because it makes Res directly affect the abdominal...
Autores principales: | Zhong, Li-Xia, Wu, Mo-Li, Li, Hong, Liu, Jia, Lin, Li-Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620774/ https://www.ncbi.nlm.nih.gov/pubmed/31456648 http://dx.doi.org/10.2147/CMAR.S206301 |
Ejemplares similares
-
Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas
por: Xue, Song, et al.
Publicado: (2016) -
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
por: Song, Xue, et al.
Publicado: (2018) -
Resveratrol, lunularin and dihydroresveratrol do not act as caloric restriction mimetics when administered intraperitoneally in mice
por: Pallauf, Kathrin, et al.
Publicado: (2019) -
Effect of intraperitoneally administered propentofylline in a rat model of postoperative pain
por: Choi, Geun Joo, et al.
Publicado: (2020) -
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells
por: Zhong, Li-Xia, et al.
Publicado: (2015)